comparemela.com
Home
Live Updates
Vivo Capital leads over $200m round in Chinese biotech firm Avistone : comparemela.com
Vivo Capital leads over $200m round in Chinese biotech firm Avistone
Private equity companies Bain Capital and Primavera Capital also participated in the round.
Related Keywords
China ,
California ,
United States ,
Palo Alto ,
Shan Fu ,
Zhejiang ,
Chinese ,
,
Avistone Pharmaceuticals ,
Sinovac Biotech ,
Zai Lab ,
Bain Capital ,
Primavera Capital ,
Pearl Biotechnology ,
Greater China ,
Vivo Capital ,
Greater China Deal Review ,
Wuxi Apptec ,
comparemela.com © 2020. All Rights Reserved.